Cargando…
Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation
Monocyte/macrophages of patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) are defective in phagocytosis and degradation amyloid β(1–42) (Aβ(1–42)), but are improved by ω-3 fatty acids (ω-3s). The hypothesis of this study was that active Aβ(1–42) phagocytosis by macrophages pre...
Autores principales: | Famenini, Sam, Rigali, Elizabeth A., Olivera-Perez, Henry M., Dang, Johnny, Chang, Michael To, Halder, Ramesh, Rao, Rammohan V., Pellegrini, Matteo, Porter, Verna, Bredesen, Dale, Fiala, Milan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of American Societies for Experimental Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161513/ https://www.ncbi.nlm.nih.gov/pubmed/27677546 http://dx.doi.org/10.1096/fj.201600677RR |
Ejemplares similares
-
Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?
por: Fiala, Milan, et al.
Publicado: (2018) -
Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016) -
Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production
por: Halder, Ramesh C., et al.
Publicado: (2015) -
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
por: Rao, Rammohan V., et al.
Publicado: (2023) -
mCiRNA—Synaptic Crystal Ball?
por: Bredesen, Dale
Publicado: (2012)